MARKET

TDSGF

TDSGF

Telo Genomics
OTCMQB
0.036
0.000
0.00%
Closed 14:03 10/30 EDT
OPEN
0.036
PREV CLOSE
0.036
HIGH
0.036
LOW
0.036
VOLUME
10.00K
TURNOVER
360
52 WEEK HIGH
0.065
52 WEEK LOW
0.028
MARKET CAP
3.62M
P/E (TTM)
-2.1557
1D
5D
1M
3M
1Y
5Y
1D
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
Newsfile · 3d ago
Weekly Report: what happened at TDSGF last week (1019-1023)?
Weekly Report · 6d ago
Weekly Report: what happened at TDSGF last week (1012-1016)?
Weekly Report · 10/19 10:10
Weekly Report: what happened at TDSGF last week (1005-1009)?
Weekly Report · 10/12 10:15
Weekly Report: what happened at TDSGF last week (0928-1002)?
Weekly Report · 10/05 10:15
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
Newsfile · 09/29 07:30
Weekly Report: what happened at TDSGF last week (0921-0925)?
Weekly Report · 09/28 10:10
Weekly Report: what happened at TDSGF last week (0914-0918)?
Weekly Report · 09/21 10:11
More
About TDSGF
Telo Genomics Corp. is a molecular diagnostics company that is engaged in developing the telomere analysis platform Teloview to enable the development of diagnostic and prognostic applications based on the quantification of genomic instability as a disease predictor. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. It quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.

Webull offers Telo Genomics Corp stock information, including OTCMQB: TDSGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TDSGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TDSGF stock methods without spending real money on the virtual paper trading platform.